Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 15;7(9):5738-49.
eCollection 2014.

The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder

Affiliations
Review

The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder

Megan C Smith et al. Int J Clin Exp Pathol. .

Abstract

Epstein Barr virus (EBV)-related hemophagocytic lymphohistiocytosis (EBV-HLH) is a form of acquired, infection-related HLH which typically represents a fulminant presentation of an acute EBV infection of CD8+ T cells with 30-50% mortality rate. Systemic EBV-positive lymphoproliferative disease of childhood (SE-LPD) is a rare T cell lymphoproliferative disorder predominantly arising in the setting of acute EBV infection, often presenting with HLH. Since both entities have been associated with clonal T cell populations, the discrimination between these diseases is often ambiguous. We report a unique case of a 21 years old female who presented with clinical and laboratory findings of florid HLH in the setting of markedly elevated EBV titers (>1 million) and an aberrant T cell population shown to be clonal by flow cytometry, karyotype, and molecular studies. This case raises the differential of EBV-HLH versus SE-LPD. Review of the literature identified 74 cases of reported EBV-HLH and 21 cases of SE-LPD with associated HLH in 25 studies. Of those cases with available outcome data, 62 of 92 cases (67%) were fatal. Of 60 cases in which molecular clonality was demonstrated, 37 (62%) were fatal, while all 14 cases (100%) demonstrating karyotypic abnormalities were fatal. Given the karyotypic findings in this sentinel case, a diagnosis of SE-LPD was rendered. The overlapping clinical and pathologic findings suggest that EBV-HLH and SE-LPD are a biologic continuum, rather than discrete entities. The most clinically useful marker of mortality was an abnormal karyotype rather than other standards of clonality assessment.

Keywords: EBV-related HLH; EBV-related T cell lymphoma; Systemic EBV-positive lymphoproliferative disease of childhood; atypical T cell population; clonal EBV-related HLH.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Images of the diagnostic marrow. A. CD68+ immunohistochemical stain highlighting intramedullary histiocytes with intact intracytoplasmic nucleated cells (1000×). B. Wright stain aspirate smear with erythrophagocytosis and frequent intermediate sized lymphocytes with irregular nuclear contours (1000×).
Figure 2
Figure 2
Flow cytometry histograms. A. Four panels showing a discrete population (10.29% of total events, indicated in blue) with greater side scatter (and forward scatter, not shown) compared to background CD3+ T lymphocytes (red) with the following atypical immunophenotype: CD5-, CD7 dim, CD8+, CD4-, and CD2 bright. B. Histograms showing isotype controls (left) and clonality of the neoplastic population by Vbeta3 (right).
Figure 3
Figure 3
Karyogram showing inv (7) (p13q32) in 10 of 20 metaphases examined.
Figure 4
Figure 4
T-cell receptor gamma studies showing a distinct clonal band on V10 studies.

References

    1. Rickinson AB. Epstein-Barr virus in action in vivo. N Engl J Med. 1998;338:1461–1463. - PubMed
    1. Callan MF, Steven N, Krausa P, Wilson JD, Moss PA, Gillespie GM, Bell JI, Rickinson AB, McMichael AJ. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med. 1996;2:906–911. - PubMed
    1. Balfour HH Jr, Odumade OA, Schmeling DO, Mullan BD, Ed JA, Knight JA, Vezina HE, Thomas W, Hogquist KA. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis. 2013;207:80–88. - PMC - PubMed
    1. Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343:481–492. - PubMed
    1. Chuang HC, Lay JD, Hsieh WC, Su IJ. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target. Cancer Sci. 2007;98:1281–1287. - PMC - PubMed

MeSH terms

LinkOut - more resources